# Study of Safety and Efficacy of Diractin® for the Treatment of Osteoarthritis (OA) of the Knee

> **NCT00722852** · PHASE3 · COMPLETED · sponsor: **IDEA AG** · enrollment: 555 (actual)

## Conditions studied

- Osteoarthritis of the Knee

## Interventions

- **DRUG:** ketoprofen in Diractin®
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT00722852
- **Lead sponsor:** IDEA AG
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2008-06
- **Primary completion:** 2009-02
- **Final completion:** 2009-04
- **Target enrollment:** 555 (ACTUAL)
- **Last updated:** 2009-10-05


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00722852

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00722852, "Study of Safety and Efficacy of Diractin® for the Treatment of Osteoarthritis (OA) of the Knee". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT00722852. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*